Ruolo dell'alfuzosina nei disturbi di vuotamento funzionali nella donna

M. D'Armiento; R. Damiano; M. De Sio; S. Perdona; C. Santonastaso; D. Mattace Raso

Ruolo dell'alfuzosina nei disturbi di vuotamento funzionali nella donna

Translated title of the contribution: Role of alfuzosin in the treatment of functional voiding dysfunction in woman

M. D'Armiento, R. Damiano, M. De Sio, S. Perdona, C. Santonastaso, D. Mattace Raso

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article › peer-review

Abstract

Voiding dysfunction of the lower urinary tract represent a diagnostic and therapeutic challenge being the symptoms and urodynamic finding not strictly related. 34 women with urgency-frequency symptoms and post voiding residual urine were treated with alfuzosin 2,5 mg. twice daily alone or associated to oxibutinine 25 mg twice daily in patients with destrusor instability. After 30 days from therapy 69% presented a post void residual urine less than 40 ml, while 76% presented a flow max more than 15 ml/sec. At follow up 12 months the results remained unchanged. Alfuzosin alone or in association with oxibutinin can lower the urinary resistence to flow without modifying the maximum urethral pressure (MUP).

Translated title of the contribution	Role of alfuzosin in the treatment of functional voiding dysfunction in woman
Original language	Italian
Pages (from-to)	43-45
Number of pages	3
Journal	Archivio Italiano di Urologia e Andrologia
Volume	69
Issue number	1 SUPPL.
Publication status	Published - 1997

ASJC Scopus subject areas

Nephrology
Urology

Fingerprint Dive into the research topics of 'Role of alfuzosin in the treatment of functional voiding dysfunction in woman'. Together they form a unique fingerprint.

Cite this

@article{c19e18e39f32482d897452594262461c,

title = "Ruolo dell'alfuzosina nei disturbi di vuotamento funzionali nella donna",

abstract = "Voiding dysfunction of the lower urinary tract represent a diagnostic and therapeutic challenge being the symptoms and urodynamic finding not strictly related. 34 women with urgency-frequency symptoms and post voiding residual urine were treated with alfuzosin 2,5 mg. twice daily alone or associated to oxibutinine 25 mg twice daily in patients with destrusor instability. After 30 days from therapy 69% presented a post void residual urine less than 40 ml, while 76% presented a flow max more than 15 ml/sec. At follow up 12 months the results remained unchanged. Alfuzosin alone or in association with oxibutinin can lower the urinary resistence to flow without modifying the maximum urethral pressure (MUP).",

keywords = "alfusozin, female, voiding dysfunction",

author = "M. D'Armiento and R. Damiano and {De Sio}, M. and S. Perdona and C. Santonastaso and {Mattace Raso}, D.",

year = "1997",

language = "Italian",

volume = "69",

pages = "43--45",

journal = "Archivio Italiano di Urologia Nefrologia Andrologia",

issn = "1120-8538",

publisher = "Edizioni Scripta Manent s.n.c.",

number = "1 SUPPL.",

}

TY - JOUR

T1 - Ruolo dell'alfuzosina nei disturbi di vuotamento funzionali nella donna

AU - D'Armiento, M.

AU - Damiano, R.

AU - De Sio, M.

AU - Perdona, S.

AU - Santonastaso, C.

AU - Mattace Raso, D.

PY - 1997

Y1 - 1997

N2 - Voiding dysfunction of the lower urinary tract represent a diagnostic and therapeutic challenge being the symptoms and urodynamic finding not strictly related. 34 women with urgency-frequency symptoms and post voiding residual urine were treated with alfuzosin 2,5 mg. twice daily alone or associated to oxibutinine 25 mg twice daily in patients with destrusor instability. After 30 days from therapy 69% presented a post void residual urine less than 40 ml, while 76% presented a flow max more than 15 ml/sec. At follow up 12 months the results remained unchanged. Alfuzosin alone or in association with oxibutinin can lower the urinary resistence to flow without modifying the maximum urethral pressure (MUP).

AB - Voiding dysfunction of the lower urinary tract represent a diagnostic and therapeutic challenge being the symptoms and urodynamic finding not strictly related. 34 women with urgency-frequency symptoms and post voiding residual urine were treated with alfuzosin 2,5 mg. twice daily alone or associated to oxibutinine 25 mg twice daily in patients with destrusor instability. After 30 days from therapy 69% presented a post void residual urine less than 40 ml, while 76% presented a flow max more than 15 ml/sec. At follow up 12 months the results remained unchanged. Alfuzosin alone or in association with oxibutinin can lower the urinary resistence to flow without modifying the maximum urethral pressure (MUP).

KW - alfusozin

KW - female

KW - voiding dysfunction

UR - http://www.scopus.com/inward/record.url?scp=0031006889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031006889&partnerID=8YFLogxK

M3 - Articolo

C2 - 9181922

AN - SCOPUS:0031006889

VL - 69

SP - 43

EP - 45

JO - Archivio Italiano di Urologia Nefrologia Andrologia

JF - Archivio Italiano di Urologia Nefrologia Andrologia

SN - 1120-8538

IS - 1 SUPPL.

ER -